Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 9,281 | 9,532 | 10,047 | 4,125 | 5,021 |
| Operating Income | -9,281 | -9,532 | -10,047 | -4,125 | -5,021 |
| Other Income | 38 | 595 | -589 | -270 | 310 |
| Pre-tax Income | -9,243 | -8,937 | -10,636 | -4,396 | -4,711 |
| Income Tax | N/A | 201 | -183 | 62 | N/A |
| Net Income Continuous | -9,243 | -9,138 | -10,453 | -4,457 | -4,711 |
| Net Income | $-9,243 | $-9,138 | $-10,453 | $-4,457 | $-4,711 |
| EPS Basic Total Ops | -0.08 | -0.09 | -0.10 | -0.05 | -0.06 |
| EPS Basic Continuous Ops | -0.08 | -0.09 | -0.10 | -0.05 | -0.06 |
| EPS Diluted Total Ops | -0.08 | -0.09 | -0.10 | -0.05 | -0.06 |
| EPS Diluted Continuous Ops | -0.08 | -0.09 | -0.10 | -0.05 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.08 | -0.10 | -0.05 | -0.06 |
| EBITDA(a) | $-9,265 | $-9,668 | $-9,978 | $-4,006 | $-5,002 |